Insider Monkey Highlights 11 Medical Technology Stocks for Investor Consideration
Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project
AnheuserBusch InBev Shares Decline After Revenue Misses Market Expectations
Aluminium Futures Edge Higher on LME Amid Firm Global Market Sentiment
CD Rates Reach Up to 4 APY as Savings Yields Remain Attractive
European Manufacturers Maintain China Supply Chains Amid EU DeRisking Efforts
GCTS Q1 2026 Earnings EPS Misses Estimates Slightly as PreRevenue Semiconductor Firm Reports Narrow Loss
KBR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Array Digital Infrastructure Inc AD Q1 2026 Earnings Massive EPS Beat Drives Optimism Amid Cautious Outlook
FISI Q1 2026 Earnings EPS Surges Past Estimates Stock Gains 24
Milestone Scientific MLSS Q1 2026 Earnings Narrower Loss Beats Estimates as Stock Edges Lower
CQP Q1 2026 Earnings Significant EPS Miss as Distributable Cash Flow Declines
AbCellera Biologics ABCL Surges 53 as Biotech Sentiment Improves
K2 Capital Acquisition KTWO Edges Higher in LowVolume Trading Near Support Levels
HCICU Holds Steady at 1004 A SPAC Unit Showing Stability Amid Market Uncertainty
PMGC Holdings ELAB Surges 1098 Breaking Above Support Testing Key Resistance
Tigo Energy Inc TYGO Slips 26 Support Test in Sight as Solar Sector Faces Headwinds
Hong Kong Poised to Strengthen Gold Hub Status with New Clearing System Expected by July
GLPG Q1 2026 Earnings Significant EPS Beat Driven by Cost Control and Operational Efficiency
Pool Corporation POOL Faces Selling Pressure as Shares Dip Below Key Levels
Nuveen Municipal Credit Income Fund NZF Rises Modestly as Steady Demand Supports FixedIncome Assets
American Financial Group Debentures AFGC Edge Lower Amid Subdued Trading
Saratoga Investment Corp Notes SAT Dip Marginally Amid Steady FixedIncome Demand
Viewbix Inc VBIX Consolidates at 364 Key Levels in Focus
Mountain Lake Acquisition Corp II MLAA Holds Steady Near SPAC NAV Amid Low Volatility
Alkermes ALKS Moves Higher on AboveAverage Volume Testing Key Resistance Zone
Maze Therapeutics MAZE Holds Steady Near Resistance as Consolidation Continues